Pricing Strategy

Precise pricing is critical to realizing maximum adoption and market value. DeciBio takes a multi-pronged approach to triangulate optimal price points for your products and services.

Our Experts

Andrew Aijian

Katie Maloney

Schedule a Call

Related Client Results

All Client Results

Pharma

Synthetic mRNA Production Landscape Assessment

A UK-based life science services provider was interested in learning more about the value and market landscape for synthetic mRNA production to inform a potential acquisition strategy

View

Voice-of-Customer Research

Competitive Analysis

Market Landscaping and Sizing

Life Science Tools & Manufacturing

Methylation Analysis Opportunity Identification for Ultra-Sensitive Detection Platform

A leader in research tools and clinical diagnostic development asked DeciBio to evaluate the opportunity for an ultra-sensitive detection platform in methylation analysis

View

Target Identification

Investors

CDD on Novel Handheld Diagnostic Device Manufacturer

A global healthcare investment firm wanted to perform a commercial due diligence (CDD) prior to investment in a company producing a novel handheld diagnostic

View

Voice-of-Customer Research

KOL Identification

Pricing Strategy

Revenue Projection

Due Diligence

Investors

Investment Diligence into Leading Oncology Diagnostic Provider

A global private equity firm wanted to project the revenues and competitive positioning of a leading oncology diagnostics provider to support a growth capital investment

View

Voice-of-Customer Research

Competitive Analysis

Revenue Projection

Due Diligence

Diagnostics

New Prenatal Opportunity Assessment

A multinational pharmaceutical and diagnostics company was interested in learning more about the U.S. market opportunity for their novel noninvasive prenatal test in development

View

Voice-of-Customer Research

Go-to-Market Strategy

Pharma

Global Companion Diagnostic Guideline Mapping and Strategy

A large pharma new to precision oncology wanted to understand the processes and requirements to ensure that their novel CDx was included into diagnostic guidelines globally

View

Biomarker and Diagnostics Strategy

Go-to-Market Strategy

Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch